3D細胞培養の世界市場は、2023年から2028年にかけて26.5%のCAGRで成長し、2023年の46億ドルから2028年には148億ドルに達すると推定されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
What's New in This Report?
Methodology and Information Sources
Geographic Breakdown
Segment Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Summary
Chapter- 3: Market Overview
An Opening Comment on an Amazing Industry
Industry Issues
Preliminary Market Analysis
Chapter- 4: Market, by Type
Where Did Tissue and Cell Culture Start?
History and Early Applications
Terminology and Concepts
Adherent Approaches
Information Technology: Software and Services for the Cell Culture Research Market
Bioprocessing Consumables for Cell Culture
Bioprocessing Equipment
Aspects of Large-Scale Manufacturing of Biopharmaceuticals and Vaccines
Small-Scale Adherent to Make Somatic Cells, Stem Cells and Tissues
Cell Culture End Users
Cell Culture Applications
Regional Markets
Chapter- 5: Assays, Imaging and Analysis
Assays
Imaging Technology
Analytical Systems Used in Tissue and Cell Culture
Predictive Toxicology
Table 41 : Typical Assay Endpoints and Tests
Chapter- 6: Regulation and Standardization
U.S. Regulatory Status of Bioprinted Products
Chapter- 7: 3D Models for Cancer
Disease Modeling
Overview: Cancer at the Cellular Level
In Vivo (Animal) Testing Standard
3D Requirements
Benefits of 3D Models to Cancer Research
Breast Cancer as a Driver of 3D Cultures
Melanoma as a Driver of 3D Cultures
3D Systems in Cancer Research
3D Engineered Scaffolds
Human Cancer Model Initiative (HCMI)
Drug Sensitivity and Resistance
Cellular Signaling
Drug Screening
Cancer Metabolism
Future Horizons
Patient-Derived Cells
Chapter- 8: Landscape for Toxicology and Drug Safety Testing
Introduction
Liver
Toxicology Background
Efficacy of Cosmetics and Cosmeceuticals
Aspects of Cosmetic Toxicity Testing
Carcinogenicity and Genotoxicity
Reproductive and Developmental Toxicity
Endocrine Disruptor Screening
Toxicokinetics and ADME
In Vitro Developments
Organotypic Models
Absorption Barrier Models
Liver Toxicity
Kidney Toxicity Applications
Pancreatic Toxicology Applications
Cardiovascular Toxicity
Chapter- 9: Market Breakdown by Region
Introduction
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 10: Stem Cell Landscape
A History of Stem Cells
3D Stem Cell Culture Systems
Short Review of Stem Cell Biology
Applications
Stem Cell Research Breakthroughs
Stem Cells for Neuroscience Discovery and Development
Stem Cells for Cardiovascular Discovery
Stem Cells for the Development of Regenerative Medicine
Chapter- 11: Regenerative Medicine: Organ Transplants and Skin Substitutes
Regenerative Medicine
Skin Substitutes Industry
Tissue Engineering in Regenerative Medicine
Chapter- 12: Company Profiles
3D BIOPRINTING SOLUTIONS
3D BIOTEK LLC
4D TECHNOLOGY CORP.
ABCAM PLC
AKRON BIOTECH
AGILENT TECHNOLOGIES INC.
ALPCO
AMSBIO
BECKMAN COULTER INC.
BIOINSPIRED SOLUTIONS
BIOTIME INC.
BIOVISION INC.
CELL APPLICATIONS INC.
CELLINK
CORNING INC.
CYPROTEX
CYTIVA
CYTOO SA
EMD MILLIPORE / MERCK KGAA
EMULATE INC.
ENVISIONTEC INC.
EPITHELIX
EUROFINS SAS
GREINER BIO-ONE INTERNATIONAL GMBH
HAMILTON ROBOTICS
HUB ORGANOIDS
HUREL CORP.
INSPHERO
INVITROCUE
KIYATEC INC.
LIFENET HEALTH
LOREM VASCULAR / CYTORI THERAPEUTICS INC.
MATTEK
MIMETAS INC.
ORGANOVO HOLDINGS INC.
PERKINELMER INC.
PLASTICELL LTD.
PLURISTEM THERAPEUTICS INC.
POIETIS
PROMEGA CORP.
SEAHORSE BIOSCIENCE
STEMCELL TECHNOLOGIES
STRATATECH CORP.
SYNVIVO INC.
TAP BIOSYSTEMS
TECAN TRADING AG
ZEN-BIO INC.